SFG
ABBV icon

Summit Financial Group’s AbbVie ABBV Stock Holding History

Summit Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1.83M Sell
10,067
-70
-0.7% -$12.1K 0.65% 45
2023
Q4 		$1.57M Sell
10,137
-30
-0.3% -$4.37K 0.6% 49
2023
Q3 		$1.52M Sell
10,167
-870
-8% -$128K 0.64% 43
2023
Q2 		$1.49M Sell
11,037
-40
-0.4% -$5.87K 0.58% 48
2023
Q1 		$1.76M Hold
11,077
– – 0.67% 42
2022
Q4 		$1.79M Buy
11,077
+171
+2% +$26.2K 0.71% 42
2022
Q3 		$1.46M Buy
10,906
+648
+6% +$93K 0.61% 43
2022
Q2 		$1.57M Hold
10,258
– – 0.61% 46
2022
Q1 		$1.66M Sell
10,258
-1,726
-14% -$251K 0.56% 48
2021
Q4 		$1.62M Buy
11,984
+1,624
+16% +$192K 0.53% 57
2021
Q3 		$1.12M Sell
10,360
-740
-7% -$84.6K 0.4% 68
2021
Q2 		$1.25M Buy
11,100
+960
+9% +$108K 0.47% 63
2021
Q1 		$1.1M Buy
10,140
+225
+2% +$24.1K 0.46% 58
2020
Q4 		$1.06M Buy
9,915
+350
+4% +$33.6K 0.46% 60
2020
Q3 		$838K Hold
9,565
– – 0.42% 67
2020
Q2 		$939K Hold
9,565
– – 0.49% 60
2020
Q1 		$729K Sell
9,565
-40
-0.4% -$3.41K 0.44% 60
2019
Q4 		$851K Hold
9,605
– – 0.41% 61
2019
Q3 		$727K Sell
9,605
-2,000
-17% -$137K 0.37% 67
2019
Q2 		$844K Sell
11,605
-50
-0.4% -$3.93K 0.38% 72
2019
Q1 		$939K Sell
11,655
-50
-0.4% -$4.09K 0.73% 43
2018
Q4 		$1.08M Hold
11,705
– – 0.92% 34
2018
Q3 		$1.11M Sell
11,705
-5
-0% -$474 0.83% 44
2018
Q2 		$1.08M Sell
11,710
-200
-2% -$19.5K 0.84% 38
2018
Q1 		$1.13M Buy
11,910
+2
+0% +$220 0.88% 40
2017
Q4 		$1.15M Hold
11,908
– – 0.94% 37
2017
Q3 		$1.06M Sell
11,908
-394
-3% -$30K 0.88% 38
2017
Q2 		$893K Buy
+12,302
New +$827K 0.77% 47

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Summit Financial Group's ABBV Position: Q1 2024 in Review

Summit Financial Group reduced its AbbVie (ABBV) stake by 0.69% in Q1 2024, selling an estimated $12.1K and leaving 10,067 shares worth $1.83M. The position accounts for 0.65% of the portfolio, ranked #45.

Summit Financial Group first reported a position in ABBV in Q2 2017 and has held it in 28 quarters since. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

  • Summit Financial Group held 10,067 shares of AbbVie worth $1.83M as of Q1 2024.
  • Summit Financial Group sold 70 AbbVie shares in Q1 2024, an estimated $12.1K.
  • AbbVie made up 0.65% of Summit Financial Group's portfolio in Q1 2024, its #45 holding.
  • Summit Financial Group first reported a position in AbbVie in Q2 2017 and has held it in 28 quarters since.
  • 3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Summit Financial Group's 13F filing for Q1 2024, filed 5 Apr 2024.